[Recent outcome of intermittent androgen suppression for the prostate cancer].
Department of Urology, National Hospital Organization Chiba Medical Center.
Naohide
N
Sato
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors